Familiáris hiperkoleszterinémia: vizsgálatok itt: Egyesült Királyság
11 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleCollection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic Devices
- Where
- Glasgow
- Életkor
- 16 év and over
- People
- 12 000
- Run by
- LumiraDx UK Limited
See details and how to joinNCT07378514 - 2/3. fázisTaking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Birmingham, Sheffield, Southampton
- Életkor
- 6 év to 17 év
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - 1. fázisTaking peoplePhase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Where
- Liverpool, London, Manchester
- Életkor
- 18 év to 70 év
- People
- 132 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06451770 · EU 2025-522617-39-00 - 3. fázisFut, nem toborozLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Middlesex
- Életkor
- 2 év to 100 év
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - 1. fázisTaking peopleA Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Where
- Cambridge, London
- Életkor
- 18 év to 75 év
- People
- 90 worldwide
- Run by
- CRISPR Therapeutics AG
See details and how to joinNCT07491172 - 1. fázisTaking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Birmingham, Cambridge, Edinburgh, London, Manchester, Nottingham
- Életkor
- 18 év to 70 év
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730 - 3. fázisTaking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Southampton
- Életkor
- 2 év to 11 év
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - 3. fázisTaking peoplePhase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days
- Where
- Stockton-on-Tees
- Életkor
- 18 év and over
- People
- 426
- Run by
- A. Menarini International Licensing S.A.
See details and how to joinNCT07614958 · EU 2025-524265-24-00 - 3. fázisTaking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- London, West Midlands
- Életkor
- 6 év to 11 év
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019 - No phaseCsak meghívásosLong-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular Disease
- Where
- London
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06112327 - No phaseTaking peopleEAS Familial Hypercholesterolaemia Studies Collaboration
- Where
- London
- People
- 75 000
- Run by
- Imperial College London
See details and how to joinNCT04272697